S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Arrowhead PharmaceuticalsACADIA PharmaceuticalsAscendis Pharma A/SIonis PharmaceuticalsUltragenyx Pharmaceutical
SymbolNASDAQ:ARWRNASDAQ:ACADNASDAQ:ASNDNASDAQ:IONSNASDAQ:RARE
Price Information
Current Price$69.00$48.98$146.91$52.78$118.50
52 Week RangeBuyBuyBuyHoldBuy
MarketRank™
Overall Score1.51.81.31.41.4
Analysis Score3.43.52.53.13.3
Community Score2.53.22.62.33.3
Dividend Score0.00.00.00.00.0
Ownership Score1.71.70.81.70.0
Earnings & Valuation Score0.00.60.60.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$82.43$62.00$183.00$61.00$131.20
% Upside from Price Target19.46% upside26.58% upside24.57% upside15.57% upside10.72% upside
Trade Information
Market Cap$7.16 billion$7.84 billion$7.85 billion$7.43 billion$7.93 billion
Beta1.621.440.771.422.19
Average Volume857,442941,005194,514912,658467,422
Sales & Book Value
Annual Revenue$87.99 million$339.08 million$14.98 million$1.12 billion$103.71 million
Price / Sales81.3923.12523.856.6276.50
CashflowN/AN/AN/A$2.15 per shareN/A
Price / CashN/AN/AN/A24.55N/A
Book Value$4.51 per share$4.54 per share$15.87 per share$11.98 per share$11.32 per share
Price / Book15.3010.799.264.4110.47
Profitability
Net Income$-84,550,000.00$-235,260,000.00$-244,180,000.00$303.26 million$-402,730,000.00
EPS($0.84)($1.60)($5.25)$2.08($7.36)
Trailing P/E RatioN/AN/AN/A109.96N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-96.09%-63.92%-4,042.79%7.82%-119.19%
Return on Equity (ROE)-17.37%-40.35%-55.72%6.57%-50.69%
Return on Assets (ROA)-15.19%-34.72%-49.42%3.39%-26.87%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.51%N/A
Current Ratio7.92%7.95%14.80%10.37%4.33%
Quick Ratio7.92%7.86%14.80%10.28%4.26%
Ownership Information
Institutional Ownership Percentage65.52%93.54%N/A84.14%N/A
Insider Ownership Percentage4.00%27.70%40.00%2.40%8.20%
Miscellaneous
Employees232580330817740
Shares Outstanding103.79 million160.05 million53.42 million140.86 million66.95 million
Next Earnings Date5/6/2021 (Estimated)5/6/2021 (Estimated)3/10/2021 (Confirmed)5/5/2021 (Estimated)5/5/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.